Cargando…
Circulating Tumor DNA Is Capable of Monitoring the Therapeutic Response and Resistance in Advanced Colorectal Cancer Patients Undergoing Combined Target and Chemotherapy
Colorectal cancer (CRC) is a highly lethal disease worldwide. The majority of patients receiving targeted therapy or chemotherapy develop drug resistance, while its molecular mechanism remains to be elucidated. The plasma circulating tumor DNA (ctDNA) exhibited the potential in identifying gene vari...
Autores principales: | Cao, Hua, Liu, Xinyi, Chen, Yixin, Yang, Pan, Huang, Tanxiao, Song, Lele, Xu, Ruilian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154135/ https://www.ncbi.nlm.nih.gov/pubmed/32318348 http://dx.doi.org/10.3389/fonc.2020.00466 |
Ejemplares similares
-
Sequencing of circulating tumor DNA for dynamic monitoring of gene mutations in advanced non-small cell lung cancer
por: Xu, Ruilian, et al.
Publicado: (2018) -
Prognostic and predictive significance of circulating biomarkers in patients with advanced upper gastrointestinal cancer undergoing systemic chemotherapy
por: Li, Ningning, et al.
Publicado: (2023) -
Prognostic Factors of Colorectal Cancer: A Comparative Study on Patients With or Without Liver Metastasis
por: Peng, Honghua, et al.
Publicado: (2021) -
Case Report: Cetuximab in Combination With Chemotherapy for the Treatment of Multifocal Hepatic Metastases From Colorectal Cancer Guided by Genetic Tests
por: Qiu, Chunhui, et al.
Publicado: (2021) -
Molecular Endoscopy for the Diagnosis and Therapeutic Monitoring of Colorectal Cancer
por: Waldner, Maximilian J., et al.
Publicado: (2022)